Coronavirus Highlights Urgent Need for Science-Backed Research

News Release from Mary Ann Liebert, Inc. publishers Coronavirus Highlights Urgent Need for Science-Backed Research As an academic publisher, we publish many important resources relevant to COVID-19 such as Health Security, Viral Immunology, Telemedicine and e-Health, and Vector Borne and Zoonotic Diseases. We are keeping our finger on the pulse of the spread of COVID-19 around the world and…

alnylam

Alnylam Receives Approval for GIVLAARI™ (givosiran) by the U.S. Food and Drug Administration (FDA)

Alnylam Receives Approval for GIVLAARI™ (givosiran) by the U.S. Food and Drug Administration (FDA) …………… With a Herculean effort by Alnylam chemists, biologists, clinical collaborators and patients, the first ever GalNAc-siRNA conjugate, Givosiran (Givlaari), passed the finish line on Wednesday and was approved by the US FDA (1,2). Givosiran selectively knocksdown the AminoLevulinic Acid Synthase…

Interview with Peter A. Beal

Interview with Peter A. Beal …………… Peter A. Beal, Ph.D., Professor Department of Chemistry University of California, Davis How did you become interested in the field of oligonucleotides? My interests in therapeutic oligonucleotides can be traced back to my time as an undergraduate student at the University of North Dakota. The professor in my organic…